Mylan Institutional INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$198Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
2,502clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $133K
2020 $12K
2021 $4,937
2022 $11K
2023 $37K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Hematology & Oncology $69K
Neurology (Psychiatry & Neurology) $49K
Medical Oncology $18K
Rheumatology $9,109
Internal Medicine $5,547
Family $5,398

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Aaron Miller New York, NY Neurology (Psychiatry & Neurology) $7,766.38
Patricia Coyle East Setauket, NY Neurology (Psychiatry & Neurology) $7,054.76
John Lindsey Houston, TX Neurology (Psychiatry & Neurology) $7,034.63
Bruce Cohen Chicago, IL Neurology (Psychiatry & Neurology) $6,930.29
Rahim Remtulla Coraopolis, PA Hematology & Oncology $6,820.49
Anthony Reder Burr Ridge, IL Neurology (Psychiatry & Neurology) $6,567.19
Clyde Markowitz Philadelphia, PA Neurology (Psychiatry & Neurology) $6,564.20
Pushpendu Banerjee La Jolla, CA Medical Oncology $6,149.75
Elisavet Paplomata Madison, WI Hematology & Oncology $5,066.34
Fred Lublin New York, NY Neurology (Psychiatry & Neurology) $5,038.24

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.